| The consensus molecular subtypes of colorectal cancer J Guinney, R Dienstmann, X Wang, A De Reynies, A Schlicker, ... Nature medicine 21 (11), 1350-1356, 2015 | 5079 | 2015 |
| Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ... Cell 164 (3), 550-563, 2016 | 2152 | 2016 |
| Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer L Li, S Karanika, G Yang, J Wang, S Park, BM Broom, GC Manyam, W Wu, ... Science signaling 10 (480), eaam7479, 2017 | 306 | 2017 |
| ZKSCAN3 Is a Master Transcriptional Repressor of Autophagy S Chauhan, JG Goodwin, S Chauhan, G Manyam, J Wang, AM Kamat, ... Molecular Cell, 2013 | 297 | 2013 |
| CD30 expression defines a novel subset of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from The International DLBCL … S Hu, ZY Xu-Monette, A Balasubramanyam, GC Manyam, C Visco, ... Blood, 2013 | 297 | 2013 |
| Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406) S Kopetz, KA Guthrie, VK Morris, HJ Lenz, AM Magliocco, D Maru, Y Yan, ... Journal of Clinical Oncology 39 (4), 285-294, 2021 | 218 | 2021 |
| iBAG: integrative Bayesian analysis of high-dimensional multiplatform genomics data W Wang, V Baladandayuthapani, JS Morris, BM Broom, G Manyam, ... Bioinformatics 29 (2), 149-159, 2013 | 172 | 2013 |
| Prevalence and Clinical Implications of Epstein–Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries CY Ok, L Li, ZY Xu-Monette, C Visco, A Tzankov, GC Manyam, ... Clinical Cancer Research 20 (9), 2338-2349, 2014 | 162 | 2014 |
| A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily A Korkut, S Zaidi, RS Kanchi, S Rao, NR Gough, A Schultz, X Li, ... Cell systems 7 (4), 422-437. e7, 2018 | 160 | 2018 |
| Immune profiling and quantitative analysis decipher the clinical role of immune-checkpoint expression in the tumor immune microenvironment of DLBCL ZY Xu-Monette, M Xiao, Q Au, R Padmanabhan, B Xu, N Hoe, ... Cancer immunology research 7 (4), 644-657, 2019 | 144 | 2019 |
| Proteomic characterization and functional analysis of outer membrane vesicles of Francisella novicida suggests possible role in virulence and use as a vaccine T Pierson, D Matrakas, YU Taylor, G Manyam, VN Morozov, W Zhou, ... Journal of proteome research 10 (3), 954-967, 2011 | 143 | 2011 |
| Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma Q Ye, ZY Xu-Monette, A Tzankov, L Deng, X Wang, GC Manyam, C Visco, ... Oncotarget 7 (3), 2401, 2015 | 137 | 2015 |
| Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer AM Sarshekeh, S Advani, MJ Overman, G Manyam, BK Kee, ... PLoS One 12 (3), e0173345, 2017 | 106 | 2017 |
| Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer MS Lee, EJ McGuffey, JS Morris, G Manyam, V Baladandayuthapani, ... British journal of cancer 114 (12), 1352-1361, 2016 | 104 | 2016 |
| Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma ZY Xu-Monette, L Li, JC Byrd, KJ Jabbar, GC Manyam, C Maria de Winde, ... Blood, The Journal of the American Society of Hematology 128 (26), 3083-3100, 2016 | 101 | 2016 |
| ATR inhibition induces CDK1–SPOP signaling and enhances anti–PD-L1 cytotoxicity in prostate cancer Z Tang, PG Pilié, C Geng, GC Manyam, G Yang, S Park, D Wang, S Peng, ... Clinical Cancer Research 27 (17), 4898-4909, 2021 | 95 | 2021 |
| The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity Y Xiao, Q Zou, X Xie, T Liu, HS Li, Z Jie, J Jin, H Hu, G Manyam, L Zhang, ... Journal of Experimental Medicine 214 (5), 1493-1507, 2017 | 95 | 2017 |
| Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL … L Deng, ZY Xu-Monette, S Loghavi, GC Manyam, Y Xia, C Visco, J Huh, ... Leukemia 30 (2), 361-372, 2016 | 91 | 2016 |
| The deubiquitinase Otub1 controls the activation of CD8+ T cells and NK cells by regulating IL-15-mediated priming X Zhou, J Yu, X Cheng, B Zhao, GC Manyam, L Zhang, K Schluns, P Li, ... Nature immunology 20 (7), 879-889, 2019 | 85 | 2019 |
| Targeting DNA damage response in prostate cancer by inhibiting androgen receptor-CDC6-ATR-Chk1 signaling S Karanika, T Karantanos, L Li, J Wang, S Park, G Yang, X Zuo, JH Song, ... Cell reports 18 (8), 1970-1981, 2017 | 85 | 2017 |
Jeffrey S. MorrisUniversity of PennsylvaniaEmail verificata su pennmedicine.upenn.edu